The Germany-based, Ammann and Staidson-backed inflammatory disease therapy developer has floated in an initial public offering in the US.

The Intel Capital-backed gaming equipment and accessories provider will float near the top of its range in Hong Kong.

The bacterial infections drug developer, based on research at Harvard Medical School, has gone public.

The bacterial infections drug developer, backed by Alphabet, Partners Healthcare, GlaxoSmithKline, Merck & Co and Lundbeck, has gone public.

The Intel and Itochu-backed cybersecurity software provider will float at the top of its range having also increased the number of shares in the offering.

The Tencent-backed online services provider floated above its range, showing the promise in Southeast Asia for Chinese internet companies.

Intel, Dell, Red Hat and Salesforce-backed database software provider MongoDB will float above its range at a market valuation of almost $1.2bn.

The Ant Financial-backed online lender floated above its range, while fellow corporate investor Kunlun Tech sold $14m of shares.

Spero Therapeutics, a bacterial infection treatment developer based on research at Harvard Medical School, has filed to raise up to $86.3m in an initial public offering.